{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:06:38Z","timestamp":1793142398117,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071589"],"award-info":[{"award-number":["82071589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC2000400"],"award-info":[{"award-number":["2018YFC2000400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bcp.2022.115045","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T11:04:06Z","timestamp":1650107046000},"page":"115045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling"],"prefix":"10.1016","volume":"200","author":[{"given":"Weitong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiepeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7501","key":"10.1016\/j.bcp.2022.115045_b0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","author":"van Deursen","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2022.115045_b0010","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2022.115045_b0015","first-page":"324","article-title":"Cellular senescence and the senescent secretory phenotype in age-related chronic diseases","volume":"17","author":"Zhu","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bcp.2022.115045_b0020","doi-asserted-by":"crossref","unstructured":"N. Ohtani, D.J. Mann, E.J.C.S. Hara, Cellular senescence: Its role in tumor suppression and aging 100 (2010) 792\u2013797.","DOI":"10.1111\/j.1349-7006.2009.01123.x"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2022.115045_b0030","doi-asserted-by":"crossref","unstructured":"B. Ritschka et al., The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration 31 (2017) 172.","DOI":"10.1101\/gad.290635.116"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07825-3","article-title":"Impaired immune surveillance accelerates accumulation of senescent cells and aging","volume":"9","author":"Ovadya","year":"2018","journal-title":"Nat. Commun."},{"issue":"5765","key":"10.1016\/j.bcp.2022.115045_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.1122446","article-title":"Cellular senescence in aging primates","volume":"311","author":"Herbig","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115045_b0045","doi-asserted-by":"crossref","unstructured":"M. Xu et al., Transplanted senescent cells induce an osteoarthritis-like condition in mice, J. Gerontol. A Biol. Sci. Med. Sci. 72 (2017) 780\u2013785. doi:10.1093\/gerona\/glw154.","DOI":"10.1093\/gerona\/glw154"},{"issue":"7372","key":"10.1016\/j.bcp.2022.115045_b0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2022.115045_b0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles' heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.bcp.2022.115045_b0060","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.18632\/aging.101100","article-title":"Discovery of piperlongumine as a potential novel lead for the development of senolytic agents","volume":"8","author":"Wang","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.bcp.2022.115045_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.18632\/aging.101787","article-title":"The curcumin analog EF24 is a novel senolytic agent","volume":"11","author":"Li","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00314-z","article-title":"Identification of HSP90 inhibitors as a novel class of senolytics","volume":"8","author":"Fuhrmann-Stroissnigg","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2022.115045_b0085","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41598-017-01964-1","article-title":"A novel indication for panobinostat as a senolytic drug in NSCLC and HNSCC","volume":"7","author":"Samaraweera","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10522-018-9785-1","article-title":"Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K\/Akt\/mTOR pathway and induces senescent cell death by regulation of Bax\/Bcl-2 pathway","volume":"20","author":"Kumar","year":"2019","journal-title":"Biogerontology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12888-x","article-title":"Identification and characterization of cardiac glycosides as senolytic compounds","volume":"10","author":"Triana-Mart\u00ednez","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2022.115045_b0100","doi-asserted-by":"crossref","first-page":"119196","DOI":"10.1016\/j.lfs.2021.119196","article-title":"Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells","volume":"272","author":"Yang","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bcp.2022.115045_b0105","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40265-019-01163-4","article-title":"Targeting BCL2 in chronic lymphocytic leukemia and other hematologic malignancies","volume":"79","author":"Yalniz","year":"2019","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","article-title":"Targeting BCL2 for the treatment of lymphoid malignancies","volume":"51","author":"Anderson","year":"2014","journal-title":"Sem. Hematol."},{"key":"10.1016\/j.bcp.2022.115045_b0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41422-020-0314-9","article-title":"Elimination of senescent cells by beta-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice","volume":"30","author":"Cai","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bcp.2022.115045_b0125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/acel.12458","article-title":"Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice","volume":"15","author":"Roos","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2022.115045_b0130","doi-asserted-by":"crossref","first-page":"102595","DOI":"10.1016\/j.ebiom.2019.12.004","article-title":"Corrigendum to 'Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446\u2013456","volume":"52","author":"Hickson","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0135","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.18632\/aging.102772","article-title":"Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice","volume":"12","author":"Cavalcante","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.bcp.2022.115045_b0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.freeradbiomed.2005.11.002","article-title":"Bcl-2 protects against oxidative stress while inducing premature senescence","volume":"40","author":"L\u00f3pez-Diazguerrero","year":"2006","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.bcp.2022.115045_b0145","first-page":"337","article-title":"Stress-induced premature senescence of endothelial cells","volume":"21","author":"Chen","year":"2008","journal-title":"J. Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115045_b0150","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.biocel.2004.10.013","article-title":"The signals and pathways activating cellular senescence","volume":"37","author":"Ben-Porath","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2203-z","article-title":"BCL-XL expression is essential for human erythropoiesis and engraftment of hematopoietic stem cells","volume":"11","author":"Afreen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ijc.29726","article-title":"HTLV-1-associated adult T cell leukemia is highly susceptible to navitoclax due to enhanced Bax expression","volume":"138","author":"Witzens-Harig","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2022.115045_b0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/17425247.2020.1715938","article-title":"Recent advances in the combination delivery of drug for leukemia and other cancers","volume":"17","author":"Al-Attar","year":"2020","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2022.115045_b0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.bcp.2022.115045_b0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2018.04.014","article-title":"Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy","volume":"138","author":"Gao","year":"2019","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.bcp.2022.115045_b0185","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0190","doi-asserted-by":"crossref","first-page":"955","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging (Albany NY)"},{"issue":"20","key":"10.1016\/j.bcp.2022.115045_b0195","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.3390\/ijms21207591","article-title":"Regulation of platelet production and life span: role of Bcl-xL and potential implications for human platelet diseases","volume":"21","author":"Josefsson","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2022.115045_b0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development","volume":"8","author":"Cang","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115045_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13142","article-title":"Galacto-conjugation of navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity","volume":"19","author":"Gonz\u00e1lez\u2010Gualda","year":"2020","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.bcp.2022.115045_b0210","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","article-title":"A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity","volume":"25","author":"Khan","year":"2019","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2022.115045_b0215","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41564-021-00973-1","article-title":"Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials","volume":"6","author":"Rasouly","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bcp.2022.115045_b0220","doi-asserted-by":"crossref","unstructured":"M.M. Hoeper et al., Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry, Eur. Respir J., 2021. doi:10.1183\/13993003.02024-2021.","DOI":"10.1183\/13993003.02024-2021"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0225","doi-asserted-by":"crossref","DOI":"10.2174\/1574887112666170803145955","article-title":"Drug combination in clinical cancer treatments","volume":"12","author":"Lu","year":"2017","journal-title":"Rev. Recent Clin. Trials"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15384047.2015.1108485","article-title":"Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer","volume":"17","author":"Nakajima","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2022.115045_b0235","doi-asserted-by":"crossref","first-page":"e0219398","DOI":"10.1371\/journal.pone.0219398","article-title":"Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment","volume":"14","author":"Britt","year":"2019","journal-title":"PLoS One"},{"issue":"28","key":"10.1016\/j.bcp.2022.115045_b0240","doi-asserted-by":"crossref","first-page":"25883","DOI":"10.18632\/oncotarget.4540","article-title":"ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0245","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2016.03.053","article-title":"Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells","volume":"473","author":"Matsumoto","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7728","key":"10.1016\/j.bcp.2022.115045_b0250","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cmet.2019.05.006","article-title":"Acceleration of \u03b2 cell aging determines diabetes and senolysis improves disease outcomes","volume":"30","author":"Aguayo-Mazzucato","year":"2019","journal-title":"Cell Metab."},{"issue":"13","key":"10.1016\/j.bcp.2022.115045_b0260","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.18632\/aging.103177","article-title":"navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/jsp2.1082","article-title":"Autophagy and mTOR signaling during intervertebral disc aging and degeneration","volume":"3","author":"Yurube","year":"2020","journal-title":"JOR Spine"},{"issue":"2","key":"10.1016\/j.bcp.2022.115045_b0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115045_b0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellsig.2018.08.018","article-title":"Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the FOXO3a transcriptional target NOXA but independent of TRAIL","volume":"52","author":"Feehan","year":"2018","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.bcp.2022.115045_b0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2016.09.162","article-title":"BCKA down-regulates mTORC2-Akt signal and enhances apoptosis susceptibility in cardiomyocytes","volume":"480","author":"Guo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.bcp.2022.115045_b0285","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2015.6562","article-title":"mTORC2 signaling regulates Nox4-induced podocyte depletion in diabetes","volume":"25","author":"Eid","year":"2016","journal-title":"Antiox. Redox Signal"},{"issue":"3","key":"10.1016\/j.bcp.2022.115045_b0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer cell"},{"issue":"279","key":"10.1016\/j.bcp.2022.115045_b0295","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4642","article-title":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy","volume":"7","author":"Leverson","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"28","key":"10.1016\/j.bcp.2022.115045_b0300","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/onc.2011.508","article-title":"Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression","volume":"31","author":"M\u00e9rino","year":"2012","journal-title":"Oncogene"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:32:47Z","timestamp":1757770367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"alternative-id":["S0006295222001393"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115045","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115045"}}